OBJECTIVES/HYPOTHESIS: Squamous cell carcinoma arising from the nasal vestibule is a rare condition accounting for about 1% of head and neck malignancies with several peculiarities concerning both staging and treatment. The aim of this study was to compare the oncological and functional results of two different treatment modalities for the primary site: surgery and brachytherapy. STUDY DESIGN: A case series with the comparison of two different treatment modalities. METHODS: We evaluate clinical and survival data of 12 untreated patients, enrolled by a multidisciplinary tumor board, comparing oncological, functional, and esthetic results after surgery or after interstitial brachytherapy as exclusive treatments for the primary site. The functional and esthetic outcome was subjectively rated by the patients using a five-point scale. RESULTS: Locoregional control and survival are not significantly different between patients primarily treated by surgery and by brachytherapy. The functional and esthetic outcome, as assessed by the degree of satisfaction of the patients, is significantly better after primary brachytherapy than after primary surgery (P = .014). CONCLUSIONS: In our experience brachytherapy, accomplished in close cooperation between surgeons and radiation oncologists, achieves oncological results that are not different from surgery, but with a higher degree of patient satisfaction, mainly due to the esthetic outcome. LEVEL OF EVIDENCE: 4.
OBJECTIVES/HYPOTHESIS: Squamous cell carcinoma arising from the nasal vestibule is a rare condition accounting for about 1% of head and neck malignancies with several peculiarities concerning both staging and treatment. The aim of this study was to compare the oncological and functional results of two different treatment modalities for the primary site: surgery and brachytherapy. STUDY DESIGN: A case series with the comparison of two different treatment modalities. METHODS: We evaluate clinical and survival data of 12 untreated patients, enrolled by a multidisciplinary tumor board, comparing oncological, functional, and esthetic results after surgery or after interstitial brachytherapy as exclusive treatments for the primary site. The functional and esthetic outcome was subjectively rated by the patients using a five-point scale. RESULTS: Locoregional control and survival are not significantly different between patients primarily treated by surgery and by brachytherapy. The functional and esthetic outcome, as assessed by the degree of satisfaction of the patients, is significantly better after primary brachytherapy than after primary surgery (P = .014). CONCLUSIONS: In our experience brachytherapy, accomplished in close cooperation between surgeons and radiation oncologists, achieves oncological results that are not different from surgery, but with a higher degree of patient satisfaction, mainly due to the esthetic outcome. LEVEL OF EVIDENCE: 4.
Authors: Monica Maria Pagliara; Luca Tagliaferri; Jacopo Lenkowicz; Luigi Azario; Dario Giattini; Bruno Fionda; Maria Grazia Sammarco; Valentina Lancellotta; Maria Antonietta Gambacorta; Maria Antonietta Blasi Journal: In Vivo Date: 2020 Jan-Feb Impact factor: 2.155
Authors: Robbert C Bakker; Marnix G E H Lam; Sebastiaan A van Nimwegen; Antoine J W P Rosenberg; Robert J J van Es; J Frank W Nijsen Journal: J Radiat Oncol Date: 2017-06-24
Authors: Luca Tagliaferri; Ashwini Budrukkar; Jacopo Lenkowicz; Mauricio Cambeiro; Francesco Bussu; Jose Luis Guinot; Guido Hildebrandt; Bengt Johansson; Jens E Meyer; Peter Niehoff; Angeles Rovirosa; Zoltán Takácsi-Nagy; Luca Boldrini; Nicola Dinapoli; Vito Lanzotti; Andrea Damiani; Roberto Gatta; Bruno Fionda; Valentina Lancellotta; Tamer Soror; Rafael Martìnez Monge; Vincenzo Valentini; György Kovács Journal: J Contemp Brachytherapy Date: 2018-06-30